Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Total Current Liabilities (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed Total Current Liabilities for 9 consecutive years, with $96.1 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities rose 8.54% to $96.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $96.1 million through Dec 2025, up 8.54% year-over-year, with the annual reading at $96.1 million for FY2025, 8.54% up from the prior year.
  • Total Current Liabilities hit $96.1 million in Q4 2025 for Inspire Medical Systems, down from $110.8 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $110.8 million in Q3 2025 to a low of $19.4 million in Q1 2021.
  • Historically, Total Current Liabilities has averaged $62.9 million across 5 years, with a median of $64.6 million in 2024.
  • Biggest five-year swings in Total Current Liabilities: soared 122.26% in 2022 and later decreased 12.06% in 2025.
  • Year by year, Total Current Liabilities stood at $41.3 million in 2021, then soared by 48.13% to $61.2 million in 2022, then increased by 27.65% to $78.1 million in 2023, then increased by 13.31% to $88.5 million in 2024, then grew by 8.54% to $96.1 million in 2025.
  • Business Quant data shows Total Current Liabilities for INSP at $96.1 million in Q4 2025, $110.8 million in Q3 2025, and $93.4 million in Q2 2025.